The number of patients suffering from Alzheimer's is expected to grow even more as the baby boomer generation begins to age, and a new report released by the Pharmaceutical Research and Manufacturers of America (PHRMA) has revealed that there are 98 new medicines either undergoing clinical trials or being reviewed by the Food and Drug Administration that are meant to treat the disease.
"The amount of suffering that will accompany the diagnosis of Alzheimer's for 13.5 million Americans is unacceptable, and the cost will be unsustainable. In millions of American homes, Alzheimer's disease already presents a crisis. The expected increase in Alzheimer's patients portends not only more personal pain and grief, but a national crisis," John Castellani, the CEO of PHRMA, said in a statement.
It is estimated that, if there are no steps taken to treat the illness in the future, caretaking costs will rise to $1.08 trillion by 2050.
Caring for those with Alzheimer's can be an overwhelming task for many, resulting in stress and other health conditions. One way to alleviate the burden is to install a senior alert system in a residence, which a patient can use to immediately send a medical alert if they are in need of assistance.